Xavier Wittebole

10.6k total citations · 2 hit papers
102 papers, 4.5k citations indexed

About

Xavier Wittebole is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Xavier Wittebole has authored 102 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 28 papers in Pulmonary and Respiratory Medicine and 27 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Xavier Wittebole's work include Sepsis Diagnosis and Treatment (35 papers), Respiratory Support and Mechanisms (19 papers) and Intensive Care Unit Cognitive Disorders (15 papers). Xavier Wittebole is often cited by papers focused on Sepsis Diagnosis and Treatment (35 papers), Respiratory Support and Mechanisms (19 papers) and Intensive Care Unit Cognitive Disorders (15 papers). Xavier Wittebole collaborates with scholars based in Belgium, France and United States. Xavier Wittebole's co-authors include Pierre‐François Laterre, Steven M. Opal, Jean‐Louis Vincent, Sophie De Roock, Thierry Dugernier, Yasser Sakr, Daniel De Backer, Diego Castanares‐Zapatero, Philippe Hantson and Ignacio Martín‐Loeches and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Xavier Wittebole

96 papers receiving 4.4k citations

Hit Papers

A historical overview of bacteriophage therapy as an alte... 2013 2026 2017 2021 2013 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
    2013 432 citations Xavier Wittebole, Steven M. Opal et al. profile →
  2. Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit
    2018 306 citations Yasser Sakr, Ulrich Jaschinski et al. Open Forum Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Wittebole Belgium 37 1.8k 842 768 706 608 102 4.5k
Frank Stüber Germany 40 1.7k 0.9× 1.1k 1.3× 585 0.8× 867 1.2× 279 0.5× 133 5.4k
Benoît Guéry France 43 2.1k 1.2× 1.1k 1.3× 753 1.0× 471 0.7× 323 0.5× 231 6.7k
Martin Langer Italy 37 1.4k 0.7× 1.1k 1.3× 836 1.1× 404 0.6× 293 0.5× 170 4.9k
Bruno François France 43 2.9k 1.6× 1.3k 1.5× 1.9k 2.5× 865 1.2× 331 0.5× 177 7.3k
Peter Q. Eichacker United States 36 2.1k 1.2× 947 1.1× 793 1.0× 1.1k 1.6× 130 0.2× 152 5.2k
Heinz Burgmann Austria 34 1.5k 0.8× 559 0.7× 313 0.4× 466 0.7× 618 1.0× 202 4.0k
Flávia Ribeiro Machado Brazil 32 2.8k 1.5× 568 0.7× 1.3k 1.8× 806 1.1× 139 0.2× 146 5.0k
Benoît Misset France 47 2.5k 1.4× 1.4k 1.6× 2.2k 2.9× 801 1.1× 411 0.7× 163 7.2k
Éric Kipnis France 31 766 0.4× 439 0.5× 559 0.7× 337 0.5× 183 0.3× 87 3.1k
Apostolos Armaganidis Greece 44 3.1k 1.7× 1.7k 2.1× 1.4k 1.8× 774 1.1× 1.1k 1.8× 172 7.2k

Countries citing papers authored by Xavier Wittebole

Since Specialization
Citations

This map shows the geographic impact of Xavier Wittebole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Wittebole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Wittebole more than expected).

Fields of papers citing papers by Xavier Wittebole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Wittebole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Wittebole. The network helps show where Xavier Wittebole may publish in the future.

Co-authorship network of co-authors of Xavier Wittebole

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Wittebole. A scholar is included among the top collaborators of Xavier Wittebole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Wittebole. Xavier Wittebole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mesland, Jean-Baptiste, Christine Collienne, Virginie Montiel, et al.. (2025). Cytomegalovirus Blood DNAemia in Patients with Severe SARS-CoV-2 Pneumonia. Infectious Disease Reports. 17(1). 8–8.
2.
Verroken, Alexia, Julien Favresse, Ahalieyah Anantharajah, et al.. (2024). Optimized Antibiotic Management of Critically Ill Patients with Severe Pneumonia Following Multiplex Polymerase Chain Reaction Testing: A Prospective Clinical Exploratory Trial. Antibiotics. 13(1). 67–67. 4 indexed citations
3.
Liu, Xin, Suzanne L. Parker, Alexia Verroken, et al.. (2023). Population pharmacokinetics and dosing simulations of total and unbound temocillin in the plasma and CSF of neurocritically ill patients with external ventricular drain-related cerebral ventriculitis. Journal of Antimicrobial Chemotherapy. 79(2). 429–442. 1 indexed citations
4.
Lesouhaitier, Mathieu, Jean-Claude Lachérade, Antoine Guillon, et al.. (2023). Long-term immunosuppressive treatment is not associated with worse outcome in patients hospitalized in the intensive care unit for septic shock: the PACIFIC study. Critical Care. 27(1). 340–340. 6 indexed citations
5.
Crippa, Ilaria Alice, Fabio Silvio Taccone, Xavier Wittebole, et al.. (2021). The Prognostic Value of Brain Dysfunction in Critically Ill Patients with and without Sepsis: A Post Hoc Analysis of the ICON Audit. Brain Sciences. 11(5). 530–530. 6 indexed citations
6.
Kotfis, Katarzyna, Xavier Wittebole, Ulrich Jaschinski, et al.. (2019). A worldwide perspective of sepsis epidemiology and survival according to age: Observational data from the ICON audit. Journal of Critical Care. 51. 122–132. 22 indexed citations
7.
Sakr, Yasser, Ulrich Jaschinski, Xavier Wittebole, et al.. (2018). Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit. Open Forum Infectious Diseases. 5(12). ofy313–ofy313. 306 indexed citations breakdown →
8.
Vincent, Jean‐Louis, Jean‐Yves Lefrant, Katarzyna Kotfis, et al.. (2018). Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP). Intensive Care Medicine. 44(3). 337–344. 96 indexed citations
9.
Dugernier, Jonathan, Michel Hesse, Émilie Bialais, et al.. (2017). Aerosol Delivery with Two Nebulizers Through High-Flow Nasal Cannula: A Randomized Cross-Over Single-Photon Emission Computed Tomography-Computed Tomography Study. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30(5). 349–358. 48 indexed citations
10.
Achouiti, Ahmed, Dirk Föll, Thomas Vogl, et al.. (2013). S100A12 and Soluble Receptor for Advanced Glycation End Products Levels During Human Severe Sepsis. Shock. 40(3). 188–194. 28 indexed citations
11.
Hickmann, Cheryl, et al.. (2011). Nutrition en réanimation. Réanimation. 21(S1). 86–89. 1 indexed citations
12.
Wunderink, Richard G., Bruno François, D. Perrotin, et al.. (2011). Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia: A Randomized Trial. American Journal of Respiratory and Critical Care Medicine. 183(11). 1561–1568. 76 indexed citations
13.
Zoelen, Marieke A. D. van, Thomas Vogl, Dirk Foell, et al.. (2009). Expression and Role of Myeloid-related Protein-14 in Clinical and Experimental Sepsis. American Journal of Respiratory and Critical Care Medicine. 180(11). 1098–1106. 112 indexed citations
14.
Delattre, Isabelle, Flora T. Musuamba, Roger K. Verbeeck, et al.. (2009). Empirical models for dosage optimization of four β-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin. Clinical Biochemistry. 43(6). 589–598. 21 indexed citations
15.
Vincent, Jean‐Louis, Jonathan Cohen, H. Burchardi, et al.. (2005). A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTION. Shock. 23(5). 400–405. 230 indexed citations
16.
Opal, Steven M., Pierre‐François Laterre, Edward Abraham, et al.. (2004). Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*. Critical Care Medicine. 32(2). 332–341. 103 indexed citations
17.
Raftopoulos, Christian, Pierre Goffette, G. Vaz, et al.. (2003). Surgical Clipping May Lead to Better Results than Coil Embolization: Results from a Series of 101 Consecutive Unruptured Intracranial Aneurysms. Neurosurgery. 52(6). 1280–1290. 62 indexed citations
18.
Hantson, Philippe, et al.. (2003). Defibrination and systemic bleeding caused by an imported African snakebite. European Journal of Emergency Medicine. 10(4). 349–352. 4 indexed citations
19.
Laterre, Pierre-François, et al.. (2002). Surveillance of hospital-acquired infections in an intensive care department—the benefit of the full-time presence of an infection control nurse. Journal of Hospital Infection. 52(1). 56–59. 21 indexed citations
20.
Wittebole, Xavier & Pierre‐François Laterre. (2001). Prise en charge des hépatites fulminantes d'origine toxique en réanimation. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 10(4). 418–425. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Stüber Breakdown of academic impact, for papers by Benoît Guéry Breakdown of academic impact, for papers by Martin Langer Breakdown of academic impact, for papers by Bruno François Breakdown of academic impact, for papers by Peter Q. Eichacker Breakdown of academic impact, for papers by Heinz Burgmann Breakdown of academic impact, for papers by Flávia Ribeiro Machado Breakdown of academic impact, for papers by Benoît Misset Breakdown of academic impact, for papers by Éric Kipnis Breakdown of academic impact, for papers by Apostolos Armaganidis
Rankless by CCL
2026